Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025
Findings from COLLIGO-HCM reinforce Camzyos’ efficacy and safety profile in reducing left ventricular outflow tract (LVOT) obstruction and improving symptom burden... Read more.
Changan’s “Vast Ocean Plan” Accelerates – A New Era in Global Service Leadership
“Skills beyond borders, service beyond boundaries” BANGKOK–(BUSINESS WIRE)–On August 27-28, 2025, ChangAn Automobile successfully hosted its 1st... Read more.
Gossamer Bio to Present at Upcoming Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization... Read more.
Vince Announces Reporting Date for Second Quarter 2025 Financial Results
NEW YORK–(BUSINESS WIRE)–Vince Holding Corp., (NYSE: VNCE) (“VNCE” or the “Company”), a global contemporary retailer, today announced that it... Read more.
Post-Quantum Cryptography (PQC) Market Report 2025-2035 | Legacy Systems’ Complexity Challenges PQC Implementation – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Post-Quantum Cryptography (PQC) Market Report 2025-2035” has been added to ResearchAndMarkets.com’s offering.... Read more.
Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
– NeoGenomics wins summary judgment in patent infringement lawsuit against Natera; Court rules Natera’s patents are invalid for claiming ineligible subject matter... Read more.
VERINT SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Price Adequacy of Verint (NASDAQ: VRNT) Shareholder Buyout – Does $20.50 Per Share Undervalue VRNT Shares?
PHILADELPHIA–(BUSINESS WIRE)–Kaskela Law LLC is actively investigating the fairness of the recently announced buyout of Verint (NASDAQ: VRNT) shareholders... Read more.
Polestar Sets the Date for H1 2025 Results
GOTHENBURG, Sweden–(BUSINESS WIRE)–Polestar (Nasdaq: PSNY) expects to publish H1 2025 unaudited financial results on 3 September 2025, before market... Read more.
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced... Read more.
Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Morgan Stanley 23rd Annual... Read more.